In this week’s Video Forum, Joe DePinto, head of cell, gene and advanced therapies at McKesson, talks about the company’s new InspiroGene division and the impact it is expected to have on the biotech marketplace. Precision dispensing and patient management, the product pipeline for advanced therapies, and recent research from InspiroGene were among the topics discussed.
Video Forum: Joe DePinto, McKesson
New division takes aim at cell and gene therapies.
Latest
L’Oréal USA Chairman David Greenberg to receive Fragrance Foundation’s Circle of Champions Award
During his tenure, David's leadership drove a more than 50% increase in U.S. sales for L'Oréal's luxury fragrance portfolio.
CVS Pharmacy, MinuteClinic roll out updated COVID-19 vaccines nationwide
Appointments can be scheduled through the CVS Health app or CVS.com and walk-ins are accepted.
Bain: Holiday sales poised to break $1 trillion
U.S. retail sales to grow 4.5% YoY in crucial holiday shopping season in November-December.
NRF takes founding role in coalition focused on AI trust
PACT AI is bringing businesses and technical experts together to build greater accountability around rapidly evolving AI systems.